Page 38

38

Projection for Contract Year 2026 With 52% implementation of technical update (informational) With full (100%) implementation of technical update for CY 2026 rates e. Part A FFS Admin loading 1.001059 1.001059 f. 2026 Part A non-ESRD FFS USPCC $483.18 $465.49 f = [(d * e) / a / 12]

g. 2026 Part B non-ESRD FFS USPCC

$765.03 $765.03 h. 2026 non-ESRD FFS USPCC $1,248.21 $1,230.52 h = f + g

i. 2025 non-ESRD FFS USPCC from CY 2025 Rate Announcement

$1,130.85 $1,130.85

j. CY 2026 FFS growth rate 10.38% 8.81% j = h/i – 1 (rounded to hundredth of a percent)

k. Impact of increase in phase-in on CY 2026 FFS growth rate (additive impact, compared with 52% phase-in) n/a -1.57% As stated earlier, we provided the preliminary impacts on the growth rates of the technical adjustment in the CY 2026 Advance Notice, and we now provide the final impacts of the technical adjustment in this CY 2026 Rate Announcement. For the MA growth rate, the updated impact of the technical adjustment for MA-related medical education expenses on the final estimate of the 2026 non-ESRD Total USPCC (being released in this CY 2026 Rate Announcement) is as follows: the impact of the increase in the phase-in on the final estimate of the 2026 MA growth rate being released in this CY 2026 Rate Announcement (based on the change in the non-ESRD Total USPCC, which includes both FFS and Part C projections) compared to the 2026 growth rate assuming a 52 percent phase-in is -0.83 percent for 100 percent implementation of the medical education change in CY 2026. Estimates of non-ESRD USPCCs and Growth Rates Comment: A commenter expressed appreciation that CMS continues to provide stakeholders with explanatory information about the process used to project the USPCCs and FFS costs,